ABCC2 gene homepage

General information
Gene symbol ABCC2
Gene name ATP-binding cassette, sub-family C (CFTR/MRP), member 2
Chromosome 10
Chromosomal band q24
Imprinted Unknown
Genomic reference NG_011798.1
Transcript reference NM_000392.3
Associated with diseases Dubin-Johnson syndrome
Citation reference(s) -
Curators (1) LOVD-team, but with Curator vacancy
Total number of public variants reported 0
Unique public DNA variants reported 0
Individuals with public variants 0
Hidden variants 0
Date created May 03, 2013

Links to other resources
HGNC 53
Entrez Gene 1244
PubMed articles ABCC2
OMIM - Gene 601107
OMIM - Diseases Dubin-Johnson syndrome


Active transcripts


ID     

Chr     

Name     

NCBI ID     

NCBI Protein ID     

DescendingVariants     
00001868 10 ATP-binding cassette, sub-family C (CFTR/MRP), member 2 NM_000392.3 NP_000383.1 0


Copyright & disclaimer
The contents of this LOVD database are the intellectual property of the respective curator(s). Any unauthorised use, copying, storage or distribution of this material without written permission from the curator(s) will lead to copyright infringement with possible ensuing litigation. Copyright © 2013-2017. All Rights Reserved. For further details, refer to Directive 96/9/EC of the European Parliament and the Council of March 11 (1996) on the legal protection of databases.

We have used all reasonable efforts to ensure that the information displayed on these pages and contained in the databases is of high quality. We make no warranty, express or implied, as to its accuracy or that the information is fit for a particular purpose, and will not be held responsible for any consequences arising out of any inaccuracies or omissions. Individuals, organisations and companies which use this database do so on the understanding that no liability whatsoever either direct or indirect shall rest upon the curator(s) or any of their employees or agents for the effects of any product, process or method that may be produced or adopted by any part, notwithstanding that the formulation of such product, process or method may be based upon information here provided.